| Line Item | 2024-11-30 | Y/Y |
|---|---|---|
| Revenue | $85.8M | +101.1% |
| Cost of Revenue | $33.0M | +73.6% |
| Gross Profit | $52.8M | +123.2% |
| R&D Expense | $600K | +0.0% |
| Operating Income | $6.7M | +185.6% |
| Pre-tax Income | $7.1M | +188.3% |
| Income Tax | -$5.7M | -3559.4% |
| Net Income | $12.8M | +256.2% |
| EPS (Basic) | $0.57 |
| Line Item | 2024-11-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.8M | -17.9% |
| Short-term Investments | $8.9M | — |
| Accounts Receivable | $2.6M | -10.7% |
| Inventory | $20.0M | +43.8% |
| Current Assets | $51.0M | +33.4% |
| Total Assets | $71.9M | +37.5% |
| Current Liabilities | $15.4M | +78.6% |
| Line Item | 2024-11-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $11.7M | +201.6% |
| Capital Expenditures | $2.3M | +159.9% |
| Investing Cash Flow | -$11.2M | -276.9% |
| Financing Cash Flow | -$4.6M | -978.7% |
| Free Cash Flow | $9.4M | +214.2% |
| +254.1% |
| EPS (Diluted) | $0.55 | +248.6% |
| Total Liabilities |
| $17.6M |
| +75.6% |
| Stockholders' Equity | $54.4M | +28.5% |